Home » INYX'S ASHTON PHARMACEUTICALS SELECTED TO PRODUCE GENERIC DRUGS FOR EUROPEAN MARKETS
INYX'S ASHTON PHARMACEUTICALS SELECTED TO PRODUCE GENERIC DRUGS FOR EUROPEAN MARKETS
Inyx, Inc., a specialty pharmaceutical company focused on niche drug delivery technologies and products, announced today that its wholly owned U.K. subsidiary, Ashton Pharmaceuticals Ltd., has been selected by a leading Indian specialty pharmaceutical company to manufacture a range of generic drugs for the United Kingdom and other European countries.
Yahoo
Finance
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May